C5 and neoplasm: However, recent studies have revealed novel evidence that anaphylatoxin C5a, the proteolytic product of complement C5, facilitated tumor progression by promoting cell proliferation and angiogenesis and shifting the tumor microenvironment to an immune suppressive condition via myeloid-derived suppressor cell (MDSC) recruitment [16,17].